428 related articles for article (PubMed ID: 21264466)
1. Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria.
Lai MJ; Lin NT; Hu A; Soo PC; Chen LK; Chen LH; Chang KC
Appl Microbiol Biotechnol; 2011 Apr; 90(2):529-39. PubMed ID: 21264466
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978.
Lai MJ; Soo PC; Lin NT; Hu A; Chen YJ; Chen LK; Chang KC
Int J Antimicrob Agents; 2013 Aug; 42(2):141-8. PubMed ID: 23742833
[TBL] [Abstract][Full Text] [Related]
3. Membrane-Permeable Antibacterial Enzyme against Multidrug-Resistant
Chen X; Liu M; Zhang P; Leung SSY; Xia J
ACS Infect Dis; 2021 Aug; 7(8):2192-2204. PubMed ID: 34232613
[TBL] [Abstract][Full Text] [Related]
4. Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.
Peng SY; You RI; Lai MJ; Lin NT; Chen LK; Chang KC
Sci Rep; 2017 Sep; 7(1):11477. PubMed ID: 28904355
[TBL] [Abstract][Full Text] [Related]
5. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).
Huang G; Shen X; Gong Y; Dong Z; Zhao X; Shen W; Wang J; Hu F; Peng Y
BMC Infect Dis; 2014 Dec; 14():681. PubMed ID: 25495514
[TBL] [Abstract][Full Text] [Related]
7. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule.
Tekbas OF; Ogur R; Korkmaz A; Kilic A; Reiter RJ
J Pineal Res; 2008 Mar; 44(2):222-6. PubMed ID: 18289175
[TBL] [Abstract][Full Text] [Related]
8. Dual antibacterial mechanisms of nisin Z against Gram-positive and Gram-negative bacteria.
Kuwano K; Tanaka N; Shimizu T; Nagatoshi K; Nou S; Sonomoto K
Int J Antimicrob Agents; 2005 Nov; 26(5):396-402. PubMed ID: 16226432
[TBL] [Abstract][Full Text] [Related]
9. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity.
Yuan Y; Li X; Wang L; Li G; Cong C; Li R; Cui H; Murtaza B; Xu Y
Microb Biotechnol; 2021 Mar; 14(2):403-418. PubMed ID: 32519416
[TBL] [Abstract][Full Text] [Related]
10. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria.
Lim JA; Shin H; Heu S; Ryu S
J Microbiol Biotechnol; 2014 Jun; 24(6):803-11. PubMed ID: 24690638
[TBL] [Abstract][Full Text] [Related]
11. Characterization of endolysin from a Salmonella Typhimurium-infecting bacteriophage SPN1S.
Lim JA; Shin H; Kang DH; Ryu S
Res Microbiol; 2012 Apr; 163(3):233-41. PubMed ID: 22289622
[TBL] [Abstract][Full Text] [Related]
12. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity.
Kim S; Jin JS; Choi YJ; Kim J
Viruses; 2020 Nov; 12(11):. PubMed ID: 33238548
[TBL] [Abstract][Full Text] [Related]
13. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
Farrell DJ; Robbins M; Rhys-Williams W; Love WG
Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria.
Zhang S; Chang Y; Zhang Q; Yuan Y; Qi Q; Lu X
Microb Cell Fact; 2022 Aug; 21(1):171. PubMed ID: 35999567
[TBL] [Abstract][Full Text] [Related]
16. Cajanol inhibits the growth of Escherichia coli and Staphylococcus aureus by acting on membrane and DNA damage.
Liu XL; Zhang XJ; Fu YJ; Zu YG; Wu N; Liang L; Efferth T
Planta Med; 2011 Jan; 77(2):158-63. PubMed ID: 20803417
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of RND-type efflux pumps confers the FtsZ-directed prodrug TXY436 with activity against Gram-negative bacteria.
Kaul M; Zhang Y; Parhi AK; Lavoie EJ; Pilch DS
Biochem Pharmacol; 2014 Jun; 89(3):321-8. PubMed ID: 24637241
[TBL] [Abstract][Full Text] [Related]
18. Design, Screening, and Characterization of Engineered Phage Endolysins with Extracellular Antibacterial Activity against Gram-Negative Bacteria.
Sui B; Wang X; Zhao T; Zhen J; Ren H; Liu W; Zhang X; Zhang C
Appl Environ Microbiol; 2023 Jul; 89(7):e0058123. PubMed ID: 37338346
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
[TBL] [Abstract][Full Text] [Related]
20. A Novel
Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H
Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
